Winning Strokes

On last Friday the BSE Sensex closed at 57,060.87 down 460.19 points (-0.80%), while the Nifty was last seen at 17,102.55 down 142.50 points (-0.83%). The Domestic equity benchmarks went into a tailspin during fag-end of the day on concerns over rising inflation and foreign fund outflows in the wake of unstable geopolitical situations. NSE VIX gained marginally and ended at 19.42.

Meanwhile, the Russian President Vladimir Putin warned the West of a "lightning fast" response to countries who will dare to interfere in the war. In another significant development Russia halted the gas supplies to Poland and Bulgaria on Wednesday, because they refused to pay for the gas in Russian rubles, as demanded by Moscow. 

In such uncertainties, the FIIs were net sellers to the tune of Rs.3648.30 Cr while the DIIs were net buyers of Rs.3490.30 Cr.

Furthermore, India logged 3,377 new COVID-19 cases taking the country's total tally of cases to 4,30,72,176. The death toll climbed to 5,23,753 with 60 fresh fatalities.

The Indian traders are confused regarding the current direction of market, as one day it rises, then two days it falls and then rises and so on. In absence of a definite trend, I'd suggest traders to remain stock specific instead of going for Nifty or Bank Nifty. If you know the fundamental story of a company and it looks good, then slowly accumulate the stock in market declines.

#SBI Cards and Payment Services Ltd (Rs.839.85), a non-banking financial company that offers extensive credit card portfolio to individual cardholders and corporate clients came out with reasonably good set of quarterly numbers. 

In this context I am tempted to put more currency in RBL Bank Ltd (Rs.120.20), which has a similar portfolio. Around a  year back Spark Capital gave a target of Rs.300 - plus for RBL Bank. Motilal Oswal expects, a good Q4FY22 results. We can look for short term targets of Rs.151/156 in the coming days. The company is also looking to raise funds.

#In a bizarre incident, a heat wave is sweeping across Indian peninsula. According to the Indian Meteorological Department (IMD), this heatwave will likely continue over northwest India and parts of central India over the next few days, causing more households to use coolers and air conditioners. Thus an early onset of summer coupled with rising demand from business houses, has spiked up the demand for power; especially when Covid-led restrictions are being withdrawn across the board.

You can keep accumulating three power stocks: Suzlon Energy Ltd (Rs.10.05), Indowind Energy Ltd (Rs.16.75) and RattanIndia Power Ltd (Rs.5.40). In case of Reliance Power Ltd the stock gets struck up at Rs.15.50 - Rs.15.60 ranges.

#In an interesting development, according to a massive study, even mild COVID can significantly increase the risk of developing type 2 diabetes. 

Wockhardt Ltd (Rs.275.55) has a good Diabetes Drug (therapy) portfolio and hence any Diabetes related pandemic, in midst of rising Covid - 19 cases, could be a good revenue generator for the company. 

Moreover, according to, Reportlinker.com the biggest reason behind the rising demand for insulin delivery devices is diabetes, which either results in insulin resistance or the stoppage in the production of this hormone.

The IDF recorded the global prevalence of this endocrine disorder at 463 million in 2019, forecasting it to reach 578 million and 700.2 million by 2030 and 2045, respectively.

Wih this, another key driver for the insulin delivery devices market is the growing number of obese people. Obesity, which is now considered an independent risk factor for Diabetes, is a result of genetics or poor lifestyle choices.

Another factor that ups the risk of this disease (Diabetes) is aging, with a larger number of people aged above 45 years suffering from this disorder compared to younger people.

Currently, North America is the largest insulin delivery devices market because of the highly fatty diet of a large number of people, which leads to obesity and, often, diabetes. Moreover, the region has been among the first to accept technologically advanced methods of administering this hormone into the body.

In the years to come, market players will find numerous growth opportunities in the APAC region, which is home to the largest diabetic population in the world. 

This, combined with the increasing awareness on a strict care regimen, is propelling the sale of insulin delivery devices. Among the various kinds of insulin pens, pumps, and other devices, those meant for home use continue to be the most popular.

Therefore, key insulin delivery devices market players, such as Becton, Dickinson and Company, Tandem Diabetes Care Inc., Medtronic plc, Biocon Ltd., Insulet Corporation, Eli Lilly and Company, Novo Nordisk A/S, Ypsomed Holding AG, Sanofi, F. Hoffmann-La Roche Ltd., Braun Melsungen AG, Wockhardt Ltd, and Gulf Pharmaceutical Industries, are doing more to target the at-home consumer base.

Accumulate the shares of Wockhardt Ltd (Rs.275.55) near the CMP, for targets of Rs.500 plus.

#Global Vectra Helicorp Ltd (Rs.52.75), should do well in the coming days, as the skies have started to open up...and Heli - tourism sector has begun operations.